Medicinal Products

Dáil Éireann Debate, Tuesday - 21 April 2026

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Tuesday, 21 April 2026

Questions (754)

Ken O'Flynn

Question:

754. Deputy Ken O'Flynn asked the Minister for Health whether benchmarking has been carried out comparing expenditure and utilisation of salbutamol nebules in Ireland with other EU member states; and if so, to provide the findings of such benchmarking. [28041/26]

Written answers

Minister for Health

As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

• Previous Answer
• Next Answer